CompoSecure, Inc. (CMPO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing e ...

Rollins (ROL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a changing earnings pi ...

Investors might want to bet on Rio Tinto (RIO) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individual investor ...

Accessibility StatementSkip Navigation NEW YORK, Nov. 24, 2025 /PRNewswire/ -- Stagwell (NASDAQ: STGW) today announced new details on the privacy protective technology that will power its groundbreaking, industry-first AI and data platform. Through Stagwell's partnership with Harvard University's OpenDP, Stagwell and Palantir will implement novel differential privacy technologies to ensure privacy for all customers. As announced in early November 2025, the new Palantir-Stagwell solution offers Stagwell cl ...

Core Viewpoint - Vita Coco Company, Inc. has received an upgrade to "Overweight" by Stephens, reflecting a positive outlook for fiscal year 2026 and boosting investor confidence, with the stock price currently at $48.32 [1] Investment Activity - Envestnet Asset Management Inc. has increased its stake in COCO by 6%, now holding 33,243 shares valued at approximately $1.2 million, representing 0.06% ownership [2] - Vanguard Group Inc. has raised its holdings by 2.1%, owning 2,642,306 shares worth around $81 million [3] - Driehaus Capital Management LLC has increased its stake by 14.4%, holding 977,291 shares, indicating growing institutional interest in COCO [3] Stock Performance - COCO's stock price is currently $48.32, reflecting a 4.54% increase or $2.10, with fluctuations between $46.25 and $49.09 today [4] - Over the past year, COCO's stock reached a high of $50.50 and a low of $25.79, with a market capitalization of approximately $2.75 billion and a trading volume of 928,124 shares today [4]

Hong Kong-based Harbour BioMed announced on Sunday an update and advancement of its global strategic collaboration with AstraZeneca Plc (NASDAQ:AZN) , initially established in March 2025. • AZN is in positive territory. Get the market research here.Harbour BioMed is a biopharmaceutical company focused on the discovery and development of antibody therapeutics in immunology and oncology.The collaboration aims to discover and develop next-generation biotherapeutics, including antibody-drug conjugates and T cel ...

Take a look at the markets. We are sharply higher. It is the NASDAQ that is a ripper today.Up two and a3%. We're good for 500 points. Coming off the worst week, as we said, for that group since April.Bitcoin had a rough week. Risk came out of the market as you know. I think the big question we all want to know where does this leave us now.Thanksgiving approaches. Not that much time left to go in the year. I go back to what Tony Pascarelloo of Goldman Sachs said last Friday pre-open.He surveyed the landscape ...

It was a tough past week for the AI trade and the broad markets, to say the least. ...

In August, I noted Iovance Biotherapeutics ( IOVA ) had made a step in the right direction with its Q2'25 earnings, but given the previous missteps in the launch of Amtagvi, I wasn't willing to rate the name a buy,Scientist and trader of biotech stock. Focus on trading around events such as trial results and NDA/BLA approvals. Also covering companies in industries regulated by the FDA. Articles present my opinion on stocks, but don't constitute investment advice.Analyst’s Disclosure:I/we have a beneficial l ...

Key Takeaways COIN plans to buy Vector.fun to expand access to Solana and integrate broader on-chain trading.The acquisition aligns with COIN's focus on enhancing crypto utility and building its on-chain future.This marks COIN's ninth deal this year as it accelerates growth through targeted acquisitions.Coinbase Global (COIN) is set to buy Vector.fun in its efforts to expand access to Solana. Vector is an on-chain trading platform built on Solana, and when integrated into COIN’s platform, will aid users in ...